- Home
- OBLG vs TOVX Comparison
OBLG vs TOVX Comparison
Compare OBLG & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBLG
- TOVX
- Stock Information
- Founded
- OBLG 2000
- TOVX 2001
- Country
- OBLG United States
- TOVX United States
- Employees
- OBLG N/A
- TOVX N/A
- Industry
- OBLG Computer Software: Programming Data Processing
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- OBLG Technology
- TOVX Health Care
- Exchange
- OBLG Nasdaq
- TOVX Nasdaq
- Market Cap
- OBLG 3.8M
- TOVX 3.1M
- IPO Year
- OBLG N/A
- TOVX 2006
- Fundamental
- Price
- OBLG $3.77
- TOVX $1.37
- Analyst Decision
- OBLG
- TOVX Strong Buy
- Analyst Count
- OBLG 0
- TOVX 1
- Target Price
- OBLG N/A
- TOVX $6.00
- AVG Volume (30 Days)
- OBLG 61.2K
- TOVX 4.8M
- Earning Date
- OBLG 11-07-2024
- TOVX 11-12-2024
- Dividend Yield
- OBLG N/A
- TOVX N/A
- EPS Growth
- OBLG N/A
- TOVX N/A
- EPS
- OBLG N/A
- TOVX N/A
- Revenue
- OBLG $2,759,000.00
- TOVX N/A
- Revenue This Year
- OBLG N/A
- TOVX N/A
- Revenue Next Year
- OBLG N/A
- TOVX N/A
- P/E Ratio
- OBLG N/A
- TOVX N/A
- Revenue Growth
- OBLG N/A
- TOVX N/A
- 52 Week Low
- OBLG $2.81
- TOVX $1.24
- 52 Week High
- OBLG $14.80
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- OBLG 47.74
- TOVX 37.71
- Support Level
- OBLG $3.70
- TOVX $1.31
- Resistance Level
- OBLG $4.14
- TOVX $2.22
- Average True Range (ATR)
- OBLG 0.26
- TOVX 0.24
- MACD
- OBLG 0.04
- TOVX -0.00
- Stochastic Oscillator
- OBLG 50.00
- TOVX 4.51
About OBLG Oblong Inc.
Oblong Inc is a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. Mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, real estate.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.